Sign In

Kristen Fortney

CEO at BIOAGE

Kristen Fortney is a renowned expert in developing artificial intelligence approaches to discover new biology.

She is the founder and CEO of BIOAGE, a well-funded, venture-backed startup focused on applying data-driven science to target molecular pathways driving human aging.

Kristen's educational background includes a Postdoc in Aging/Genetics/Bioinformatics from Stanford University and a PhD in Bioinformatics from the University of Toronto.

Her professional experience spans across various prestigious organizations such as serving as a Scientific Advisor at Insilico Medicine, Inc, a Visiting Scholar at Okinawa Institute of Science and Technology, a Postdoctoral research fellow at Stanford University, and more.

She leads a diverse team of computational biologists, experimental scientists, and drug hunters at BIOAGE, working towards developing a range of therapies to enhance healthspan and lifespan.

Kristen Fortney's work aims to revolutionize the field of biomedicine by utilizing AI and big data to drive innovations in aging research and longevity treatments.

Highlights

Jan 30 · twitter

Important paper

Feb 13 · Business Wire
BioAge Announces $170 Million Oversubscribed Series D Financing to Accelerate Development of Obesity and ... - Business Wire
BioAge Announces $170 Million Oversubscribed Series D Financing to Accelerate Development of Obesity
Oct 26 · Forbes
New Trial Will Test Whether Weight Loss Drugs Can Work Without Shedding Muscle Mass - Forbes
New Trial Will Test Whether Weight Loss Drugs Can Work Without Shedding Muscle Mass - Forbes
Kristen Fortney
Add to my network

Location

San Francisco Bay Area